Healthy men help compare bone drug copies
NCT ID NCT05245669
First seen Dec 29, 2025 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This study tested whether a new version of the bone drug denosumab (ENZ215) works the same as two approved versions (Prolia from Europe and the US). It involved 207 healthy adult male volunteers who received a single injection. The goal was to compare how the drug moves through the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MALE SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MC Comac Medical
Sofia, Sofia City Province, 1000, Bulgaria
-
MTZ Clinical Research powered by Pratia, Pratia S.A
Warsaw, 02-172, Poland
Conditions
Explore the condition pages connected to this study.